Ovarian disorder
MONDO:0005558A disease involving the ovary.
Also known as: disease of ovary, disease or disorder of ovary, disorder of ovary, ovarian disease, ovarian disorder, ovary disease, ovary disease or disorder
1391 clinical trials for this condition and its sub-types, 10 tagged with Ovarian disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ovarian disorder
-
Ovarian neoplasm 78 trials · 1,215 incl. sub-types
8 sub-types
- Ovarian cancer 1,004 trials · 1,200 incl. sub-types Sub-types →
- Ovarian epithelial tumor 14 trials · 664 incl. sub-types Sub-types →
- Ovarian germ cell tumor 9 trials · 13 incl. sub-types Sub-types →
- Ovarian sex cord-stromal tumor 1 trial · 7 incl. sub-types Sub-types →
- Ovarian benign neoplasm 1 trial Sub-types →
- Ovarian endometrioid stromal and related neoplasms 0 trials
- Ovarian melanoma 0 trials
- Rete ovarii neoplasm 0 trials Sub-types →
-
Ovarian dysfunction 27 trials · 120 incl. sub-types
1 sub-type
- Primary ovarian failure 53 trials · 104 incl. sub-types Sub-types →
-
Ovarian endometriosis 22 trials
-
Ovarian cyst 18 trials · 19 incl. sub-types
3 sub-types
- Malignant ovarian cyst 1 trial
- Neonatal ovarian cyst 1 trial
- Corpus luteum cyst 0 trials
-
Anovulation 15 trials
-
Ovarian hyperstimulation syndrome 12 trials
-
Oophoritis 0 trials · 1 incl. sub-types
3 sub-types
- Salpingo-oophoritis 1 trial Sub-types →
- Autoimmune oophoritis 0 trials
- Tuberculous oophoritis 0 trials
-
Luteoma of pregnancy 0 trials
-
Ovarian ectopic pregnancy 0 trials
-
Ovarian remnant syndrome 0 trials
-
Ovarian stromal hyperthecosis 0 trials
Most studied deeper sub-types
-
Can engineered immune cells outsmart Drug-Resistant ovarian cancer?
Cure OngoingThis phase 1 trial tests an experimental therapy called AB-1015 in people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. AB-1015 uses a patient's own T cells, which are genetically engineered to recognize and…
Phase 1 • Sponsor: Arsenal Biosciences, Inc. • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
New drug cocktail shows promise for tough cancers
Disease control OngoingThis study is testing a combination of three drugs—durvalumab (an immunotherapy), olaparib (a targeted therapy), and bevacizumab (a drug that blocks blood vessel growth)—in people with advanced solid tumors, including ovarian, breast, lung, and gastric cancers. The goal is to see…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New algorithm aims to catch ovarian damage early in young cancer survivors
Knowledge-focused CancelledThis study was designed to see if a new monitoring algorithm could detect early signs of ovarian damage in women and girls who had cancer treatment. Researchers planned to compare a group using the new algorithm with a group that received standard care. However, the study was wit…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:42 UTC